Lung cancer surgery often results in significant postoperative symptoms for patients. Traditional postoperative care, which tends to be reactive rather than proactive, can be insufficient for managing these symptoms effectively....
Read More
Findings in JAMA Oncology suggest intensity-modulated radiotherapy improves outcomes among patients with locally advanced non-small cell lung cancer.
Read More
New findings suggest physical performance may be a key prognostic factor for overall survival in patients with metastatic non-small cell lung cancer.
Read More
An AI model was able to outperform a radiomics model in detecting epidermal growth factor receptor gene mutation in patients with NSCLC and brain metastasis.
Read MorePhysician’s Weekly (PW) spoke with Yvette C. Terrie, BS Pharm, RPh, consultant pharmacist, to gain insight into why pharmacists are a crucial part of the care team for patients with non-small-cell lung cancer (NSCLC). PW: What...
Read More
